{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T07:07:42Z","timestamp":1770188862364,"version":"3.49.0"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Sunnybrook Alternate Funding Plan Innovation Fund"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,29]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Malignant bowel obstruction in patients with stage IV gastrointestinal cancer represents a challenging scenario, with a lack of patient-centred outcome data to guide decisions. This study evaluated the association between days at home, and malignant bowel obstruction palliation treatment strategy in this subgroup of patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This population-based retrospective cohort study included adults with stage IV gastrointestinal cancer admitted for malignant bowel obstruction between 2010 and 2019. Patients with stage IV gastrointestinal cancer treated with curative intent were excluded. The primary exposure was treatment strategy at first admission with malignant bowel obstruction divided into surgical, procedural (percutaneous or endoscopic), and supportive care. The primary outcome of interest was days at home over 90 days. Multivariable quantile regression was used to evaluate the association between treatment strategy and days at home over 90 days adjusted for cancer and patient factors. Quantile plots were used to examine this association across the distribution of days at home over 90 days.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 12 923 patients admitted, 4642 were selected: 2076 (44.7%) received surgical, 310 (6.7%) procedural, and 2256 (48.6%) supportive care. Those who had surgical treatment had the highest median days at home over 90 days of 67 (interquartile range 23\u201380) days, followed 45 (7\u201378) days with procedural treatment, and 31 (0\u201376) days with supportive care. After adjusting for patient and cancer factors, surgical treatment was associated with an increase in median days at home over 90 days of 20 (95% confidence interval 15\u201324) days and procedural treatment with an increase of 14 (6\u201322) days. The directionality of these findings was stable across the distribution of days at home over 90 days, and stable in sensitivity analysis after exclusion of deaths.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Surgical and procedural treatment were associated with increased days at home over 90 days. These findings can support decision-making and expectation setting in patients eligible for surgical and procedural treatments.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/bjsopen\/zraf171","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T13:08:35Z","timestamp":1765458515000},"source":"Crossref","is-referenced-by-count":0,"title":["Impact of treatment strategy after malignant bowel obstruction in stage IV gastrointestinal cancer: population-based cohort study"],"prefix":"10.1093","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9167-8700","authenticated-orcid":false,"given":"Tiago","family":"Ribeiro","sequence":"first","affiliation":[{"name":"Department of Surgery, University of Toronto , Toronto, Ontario ,","place":["Canada"]},{"name":"Institute of Health Policy Management and Evaluation, University of Toronto , Toronto, Ontario ,","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-3290-1009","authenticated-orcid":false,"given":"Adom","family":"Bondzi-Simpson","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Toronto , Toronto, Ontario ,","place":["Canada"]},{"name":"Institute of Health Policy Management and Evaluation, University of Toronto , Toronto, Ontario ,","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Bateni","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Alabama , Birmingham, Alabama ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wing C","family":"Chan","sequence":"additional","affiliation":[{"name":"Institute for Clinical Evaluative Sciences , Toronto, Ontario ,","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalie","family":"Coburn","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Toronto , Toronto, Ontario ,","place":["Canada"]},{"name":"Institute of Health Policy Management and Evaluation, University of Toronto , Toronto, Ontario ,","place":["Canada"]},{"name":"Clinical Evaluative Sciences, Sunnybrook Research Institute , Toronto, Ontario ,","place":["Canada"]},{"name":"Division of Surgical Oncology, Odette Cancer Centre\u2014Sunnybrook Health Sciences Centre , Toronto, Ontario ,","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Calvin","family":"Law","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Toronto , Toronto, Ontario ,","place":["Canada"]},{"name":"Division of Surgical Oncology, Odette Cancer Centre\u2014Sunnybrook Health Sciences Centre , Toronto, Ontario ,","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5108-1072","authenticated-orcid":false,"given":"Julie","family":"Hallet","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Toronto , Toronto, Ontario ,","place":["Canada"]},{"name":"Institute of Health Policy Management and Evaluation, University of Toronto , Toronto, Ontario ,","place":["Canada"]},{"name":"Clinical Evaluative Sciences, Sunnybrook Research Institute , Toronto, Ontario ,","place":["Canada"]},{"name":"Division of Surgical Oncology, Odette Cancer Centre\u2014Sunnybrook Health Sciences Centre , Toronto, Ontario ,","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,2,3]]},"reference":[{"key":"2026020313285083900_zraf171-B1","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2147\/CMAR.S29297","article-title":"Malignant bowel obstruction in advanced cancer patients: epidemiology, management, and factors influencing spontaneous resolution","volume":"4","author":"Tuca","year":"2012","journal-title":"Cancer Manag Res"},{"key":"2026020313285083900_zraf171-B2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.yasu.2021.05.003","article-title":"Malignant bowel obstruction","volume":"55","author":"Fackche","year":"2021","journal-title":"Adv Surg"},{"key":"2026020313285083900_zraf171-B3","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1016\/j.jviscsurg.2015.09.014","article-title":"Abdominal surgical emergencies in patients with advanced cancer","volume":"152","author":"Dumont","year":"2015","journal-title":"J Visc Surg"},{"key":"2026020313285083900_zraf171-B4","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1001\/jamasurg.2013.4059","article-title":"Palliative surgery for malignant bowel obstruction from carcinomatosis: a systematic review","volume":"149","author":"Paul Olson","year":"2014","journal-title":"JAMA Surg"},{"key":"2026020313285083900_zraf171-B5","doi-asserted-by":"crossref","first-page":"50","DOI":"10.12927\/hcq.2017.25136","article-title":"Patient-centred care in Canada: key components and the path forward","volume":"20","author":"Montague","year":"2017","journal-title":"Healthc Q"},{"key":"2026020313285083900_zraf171-B6","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/jso.25451","article-title":"Malignant bowel obstruction","volume":"120","author":"Krouse","year":"2019","journal-title":"J Surg Oncol"},{"key":"2026020313285083900_zraf171-B7","first-page":"CD002764","article-title":"Surgery for the resolution of symptoms in malignant bowel obstruction in advanced gynaecological and gastrointestinal cancer","author":"Cousins","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"2026020313285083900_zraf171-B8","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/ans.16188","article-title":"Management of primary and metastatic malignant small bowel obstruction, operate or palliate. A systematic review","volume":"91","author":"Banting","year":"2021","journal-title":"ANZ J Surg"},{"key":"2026020313285083900_zraf171-B9","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1245\/s10434-021-10922-1","article-title":"Malignant bowel obstruction management over time: are we doing anything new? A current narrative review","volume":"29","author":"Shariff","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"2026020313285083900_zraf171-B10","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ejso.2018.12.015","article-title":"Acute malignant obstruction in patients with peritoneal carcinomatosis: the role of palliative surgery","volume":"45","author":"De Boer","year":"2019","journal-title":"Eur J Surg Oncol"},{"key":"2026020313285083900_zraf171-B11","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1089\/jpm.2013.0240","article-title":"Outcome measures other than morbidity and mortality for patients with incurable cancer and gastrointestinal obstruction","volume":"17","author":"Badgwell","year":"2014","journal-title":"J Palliat Med"},{"key":"2026020313285083900_zraf171-B12","doi-asserted-by":"crossref","first-page":"e015828","DOI":"10.1136\/bmjopen-2017-015828","article-title":"Validation of days at home as an outcome measure after surgery: a prospective cohort study in Australia","volume":"7","author":"Myles","year":"2017","journal-title":"BMJ Open"},{"key":"2026020313285083900_zraf171-B13","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/ALN.0000000000002701","article-title":"Days alive and out of hospital","volume":"131","author":"Jerath","year":"2019","journal-title":"Anesthesiology"},{"key":"2026020313285083900_zraf171-B14","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.eclinm.2019.04.011","article-title":"Days at home after surgery: an integrated and efficient outcome measure for clinical trials and quality assurance","volume":"11","author":"Bell","year":"2019","journal-title":"EClinicalMedicine"},{"key":"2026020313285083900_zraf171-B15","doi-asserted-by":"crossref","first-page":"e308","DOI":"10.1200\/JOP.18.00338","article-title":"Days at home in the last 6 months of life: a patient-determined quality indicator for cancer care","volume":"15","author":"Andersen","year":"2019","journal-title":"JOP"},{"key":"2026020313285083900_zraf171-B16","doi-asserted-by":"crossref","first-page":"znae278","DOI":"10.1093\/bjs\/znae278","article-title":"Days at home after surgery as a perioperative outcome: scoping review and recommendations for use in health services research","volume":"111","author":"Ribeiro","year":"2024","journal-title":"Br J Surg"},{"key":"2026020313285083900_zraf171-B17","author":"Health Canada"},{"key":"2026020313285083900_zraf171-B18","doi-asserted-by":"crossref","first-page":"e1001885","DOI":"10.1371\/journal.pmed.1001885","article-title":"The REporting of studies conducted using observational routinely-collected health data (RECORD) statement","volume":"12","author":"Benchimol","year":"2015","journal-title":"PLoS Med"},{"key":"2026020313285083900_zraf171-B19","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1097\/MLR.0b013e31819432e5","article-title":"A modification of the Elixhauser comorbidity measures into a point system for hospital death using administrative data","volume":"47","author":"van Walraven","year":"2009","journal-title":"Med Care"},{"key":"2026020313285083900_zraf171-B20","author":"Kralj"},{"key":"2026020313285083900_zraf171-B21","doi-asserted-by":"crossref","first-page":"260","DOI":"10.17269\/s41997-021-00552-1","article-title":"The 2011 and 2016 iterations of the Ontario Marginalization Index: updates, consistency and a cross-sectional study of health outcome associations","volume":"113","author":"van Ingen","year":"2022","journal-title":"Can J Public Health"},{"key":"2026020313285083900_zraf171-B22","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1186\/s12889-016-3327-z","article-title":"Material deprivation and health: a longitudinal study","volume":"16","author":"T\u00f8ge","year":"2016","journal-title":"BMC Public Health"},{"key":"2026020313285083900_zraf171-B23","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2307\/1913643","article-title":"Regression quantiles","volume":"46","author":"Koenker","year":"1978","journal-title":"Econometrica"},{"key":"2026020313285083900_zraf171-B24","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1213\/ANE.0000000000004017","article-title":"Quantile regression and its applications: a primer for anesthesiologists","volume":"128","author":"Staffa","year":"2019","journal-title":"Anesth Analg"},{"key":"2026020313285083900_zraf171-B25","doi-asserted-by":"crossref","first-page":"311","DOI":"10.5694\/mja2.51658","article-title":"Hospital costs and factors associated with days alive and at home after surgery","volume":"217","author":"Reilly","year":"2022","journal-title":"Med J Aust"},{"key":"2026020313285083900_zraf171-B26","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1080\/0284186X.2022.2156810","article-title":"Days alive and out of hospital following primary surgery for oral cavity squamous cell carcinoma","volume":"61","author":"Awada","year":"2022","journal-title":"Acta Oncologica"},{"key":"2026020313285083900_zraf171-B27","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1136\/bmjqs-2021-013150","article-title":"Days alive and at home after hip fracture: a cross-sectional validation of a patient-centred outcome measure using routinely collected data","volume":"32","author":"McIsaac","year":"2023","journal-title":"BMJ Qual Saf"},{"key":"2026020313285083900_zraf171-B28","doi-asserted-by":"crossref","first-page":"e1348","DOI":"10.1097\/SLA.0000000000005387","article-title":"Long-term functional outcomes among older adults undergoing video-assisted versus open surgery for lung cancer: a population-based cohort study","volume":"277","author":"Hallet","year":"2023","journal-title":"Ann Surg"},{"key":"2026020313285083900_zraf171-B29","doi-asserted-by":"crossref","first-page":"e368","DOI":"10.1097\/SLA.0000000000005660","article-title":"Long-term dependency in older adults after surgery or stereotactic body radiation therapy for stage I non-small cell lung cancer","volume":"278","author":"Hirpara","year":"2023","journal-title":"Ann Surg"},{"key":"2026020313285083900_zraf171-B30","doi-asserted-by":"crossref","first-page":"e203754","DOI":"10.1001\/jamasurg.2020.3754","article-title":"Patient-centered time-at-home outcomes in older adults after surgical cancer treatment","volume":"155","author":"Chesney","year":"2020","journal-title":"JAMA Surg"},{"key":"2026020313285083900_zraf171-B31","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/SLA.0000000000005151","article-title":"Minimally invasive compared to open colorectal cancer resection for older adults: a population-based analysis of long-term functional outcomes","volume":"277","author":"Behman","year":"2023","journal-title":"Ann Surg"},{"key":"2026020313285083900_zraf171-B32","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.6004\/jnccn.2022.7052","article-title":"Association between frailty and time alive and at home after cancer surgery among older adults: a population-based analysis","volume":"20","author":"Hallet","year":"2022","journal-title":"J Natl Compr Canc Netw"},{"key":"2026020313285083900_zraf171-B33","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1177\/0269216309346544","article-title":"Room for improvement? A quality-of-life assessment in patients with malignant bowel obstruction","volume":"24","author":"Selby","year":"2010","journal-title":"Palliat Med"},{"key":"2026020313285083900_zraf171-B34","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1002\/cam4.1111","article-title":"Longitudinal study of quality of life in advanced cancer patients on home parenteral nutrition","volume":"6","author":"Cotogni","year":"2017","journal-title":"Cancer Med"},{"key":"2026020313285083900_zraf171-B35","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/jgs.15705","article-title":"Home time as a patient-centered outcome in administrative claims data","volume":"67","author":"Lee","year":"2019","journal-title":"J Am Geriatr Soc"},{"key":"2026020313285083900_zraf171-B36","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1080\/10428194.2019.1654095","article-title":"Days spent at home in the last 6 months of life: a quality indicator of end of life care in patients with hematologic malignancies","volume":"61","author":"Cheung","year":"2020","journal-title":"Leuk Lymphoma"},{"key":"2026020313285083900_zraf171-B37","doi-asserted-by":"crossref","first-page":"4249","DOI":"10.1002\/cncr.33817","article-title":"Healthy days at home: a population-based quality measure for cancer patients at the end of life","volume":"127","author":"Lam","year":"2021","journal-title":"Cancer"},{"key":"2026020313285083900_zraf171-B38","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/00002820-200306000-00012","article-title":"When death is imminent: where terminally ill patients with cancer prefer to die and why","volume":"26","author":"Tang","year":"2003","journal-title":"Cancer Nurs"},{"key":"2026020313285083900_zraf171-B39","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/S2468-1253(23)00191-7","article-title":"Surgical versus non-surgical management for patients with malignant bowel obstruction (S1316): a pragmatic comparative effectiveness trial","volume":"8","author":"Krouse","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2026020313285083900_zraf171-B40","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.trecan.2023.01.006","article-title":"The unequal burden of time toxicity","volume":"9","author":"Johnson","year":"2023","journal-title":"Trends Cancer"}],"container-title":["BJS Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bjsopen\/article-pdf\/10\/1\/zraf171\/66731322\/zraf171.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjsopen\/article-pdf\/10\/1\/zraf171\/66731322\/zraf171.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T18:29:02Z","timestamp":1770143342000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjsopen\/article\/doi\/10.1093\/bjsopen\/zraf171\/8456587"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,29]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12,29]]}},"URL":"https:\/\/doi.org\/10.1093\/bjsopen\/zraf171","relation":{},"ISSN":["2474-9842"],"issn-type":[{"value":"2474-9842","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,2]]},"published":{"date-parts":[[2025,12,29]]},"article-number":"zraf171"}}